Disclosure Of Earnings Per Share [Text Block]

Innate Pharma - Filing #858132

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Disclosure of earnings per share [text block]
Résultat par action
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
73.00
57.00
Basic earnings (loss) per share from discontinued operations
9.00
Basic earnings (loss) per share
73.00
66.00
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations
73.00
57.00
Diluted earnings (loss) per share from discontinued operations
9.00
Diluted earnings (loss) per share
73.00
66.00
Weighted average ordinary shares used in calculating basic and diluted earnings per share [abstract]
Weighted average number of ordinary shares used in calculating diluted earnings per share
79 639 826 xbrli:shares
79 542 627 xbrli:shares
Disclosure of depositary receipts [text block]
Disclosure of depositary receipts [abstract]
Disclosure of depositary receipts [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.